Topic: Excessive pricing

Blue Cross and Blue Shield of Minnesota has sued former pharmaceutical company executive Martin Shkreli over his alleged scheme to monopolise the market for antiparasitic drug Daraprim.

05 March 2021

The European Commission has closed its excessive pricing investigation into Aspen, after the drugmaker committed to reduce the price of six of its cancer medicines and continue supplying them across the EU.

10 February 2021

Brazil’s antitrust watchdog has imposed interim measures on a pair of port operators to stop them charging freight companies additional fees to use rivals’ warehouses, on the same day it fined a third port operator €1.3 million for charging the same fee.

09 February 2021

The UK's Supreme Court has permitted Flynn Pharma and Pfizer to appeal against a ruling that required the drug companies to pay the costs of their successful appeal against a decision by the UK's Competition and Markets Authority.

27 January 2021

A proposed opt-out collective action worth nearly £600 million has been filed at the UK's Competition Appeal Tribunal against the country's leading telecommunications provider for allegedly charging 2.3 million customers excessive prices.

18 January 2021

Epic Games has asked the UK’s specialist competition tribunal to censure Apple and Google for removing its Fortnite game from their app stores, as part of a new claim that closely mirrors those it has already filed in the US and Australia.

15 January 2021

A South African appellate court has upheld a controversial decision to sanction a mask supplier for charging excessive prices during the initial stages of the coronavirus pandemic, but annulled the company’s actual fine due to the limited scope of the infringement.

19 November 2020

A federal judge in Illinois has ruled that a small, family-owned New York deli can continue to pursue claims on behalf of a class of indirect purchasers that paid higher prices for turkeys because of a conspiracy between some of the country’s largest suppliers.

27 October 2020

The UK’s Competition and Markets Authority has dropped its fourth and final coronavirus-linked excessive pricing probe, after concluding that the prices charged by a pharmacy were unlikely to have breached competition rules.

04 September 2020

The US Court of Appeals for the Ninth Circuit has reversed a lower court’s finding that Qualcomm’s licensing practices violated federal antitrust law.

12 August 2020